A week after suspending a major HIV vaccine trial set to commence soon, linkurl:Anthony Fauci,;http://www.the-scientist.com/article/display/13734/ head of the National Institute of Allergies and Infectious Diseases (NIAID), has laid out a plan for reshuffling priorities in HIV/AIDS vaccine development in an article appearing in Science tomorrow (July 25), coauthored by a slew of HIV vaccine researchers. "The general trend will be funding a bit more fundamental discovery research," Fauci said, echoing a linkurl:pledge;http://www.the-scientist.com/blog/display/54488/ he made at an NIAID conference back in March. NIAID is still solidifying some future initiatives, Fauci said, such as plans to attract more young investigators to HIV vaccine research by offering more grants for such studies, and to encourage more collaboration between non-human primate researchers and scientists at human clinical centers. The NIAID is also planning a November conference on non-human primate research on HIV vaccines, Fauci said, and in May funded a linkurl:$15.6 million project;http://www.the-scientist.com/blog/display/54655/ to...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?